How RecursiveMAS speeds up multi-agent inference by 2.4x and reduces token usage by 75%

UIUC and Stanford's RecursiveMAS lets AI agents collaborate in embedding space instead of text, cutting token usage by 75% ...
CNBC

Recursion Pharmaceuticals CEO explains how AI could make drug development faster and less costly

Monday - Friday, 6:00 - 7:00 PM ET In a Friday interview with CNBC's Jim Cramer, Recursion Pharmaceuticals CEO Chris Gibson discussed how his company is using artificial intelligence and machine ...
Yahoo Finance

Will Recursion Pharmaceuticals’ (RXRX) New CEO Accelerate Its AI Ambitions and Strategic Partnerships?

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Ventureburn

Recursive Superintelligence Raises $500M Funding Round

Recursive Superintelligence raises $500M to accelerate AI innovation, signaling strong investor confidence in next-gen intelligence systems.
Science Daily

Recursive Splicing: Carnegie Mellon University Research Reveals How Cells Process Large Genes

Important messages require accurate transmission. Big genes are especially challenging. During processing, introns (non-coding elements) are snipped out and exons (coding segments) pasted together to ...
The Motley Fool

4 Things You Need to Know if You Buy Recursion Pharmaceuticals Stock Today

Recursion stands out as a pure play in AI-powered biotech, using machine learning algorithms to accelerate drug research and development (R&D). The company's BioHive-2 supercomputer, powered by Nvidia ...